Terlipressin Recruiting Phase 3 Trials for Terlipressin Adverse Reaction Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04028505Terlipressin Infusion in Variceal Hemorrhage